{"id":"CHEMBL104444","canonicalSmiles":"CNC1Cc2ccccc2C(c2ccccc2)C1","inchiKey":"HLOCJJORRHQDKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL104444","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL107360","canonicalSmiles":"c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2","inchiKey":"JCBQCKFFSPGEDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINUPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinupramine"],"crossReferences":{"drugbank":["DB13246"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1084081","canonicalSmiles":"O=C(O)c1ccc(B(O)O)cc1NS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)cs1","inchiKey":"JJPKFZAOXOEFHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084081","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1095777","canonicalSmiles":"CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2","inchiKey":"QZZUEBNBZAPZLX-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDACATEROL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Indacaterol","Indacterol","Onbrez","QAB-149","QAB149","QABI49"],"crossReferences":{"Wikipedia":["Indacaterol"],"drugbank":["DB05039"],"chEBI":["68575"]},"childChemblIds":["CHEMBL1789842","CHEMBL3527369","CHEMBL4297657"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0003144","EFO_0000464","EFO_0006505","MONDO_0004979","EFO_0000341","HP_0002110"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL1096882","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"GIUYCYHIANZCFB-FJFJXFQQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUDARABINE PHOSPHATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"crossReferences":{"DailyMed":["fludarabine%20phosphate"],"chEBI":["63599"]},"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000167325","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0003811","EFO_1001257","EFO_1000403","EFO_0000637","EFO_0000756","EFO_0000681","EFO_0005952","EFO_0006803","EFO_1000318","MONDO_0015760","MONDO_0020511","EFO_0000339","EFO_0000096","EFO_0000588","EFO_1000956","EFO_1001935","Orphanet_3319","MONDO_0008903","EFO_0002690","EFO_0000676","MONDO_0015277","Orphanet_379","Orphanet_42738","MONDO_0000159","EFO_0000198","MONDO_0013730","EFO_0000221","EFO_0005803","MONDO_0019465","EFO_0001642","EFO_1000309","EFO_0000384","MONDO_0008315","EFO_1000026","MONDO_0002691","HP_0002721","MONDO_0009453","MONDO_0044889","EFO_0003032","MONDO_0019472","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000550","Orphanet_231214","EFO_1000142","Orphanet_84","MONDO_0044903","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0003541","EFO_0002430","MONDO_0002158","MONDO_0002898","EFO_1001996","EFO_0004289","EFO_0000196","EFO_0000183","MONDO_0002083","Orphanet_447","EFO_1000388","EFO_0000616","EFO_1001779","EFO_0006859","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0007576","MONDO_0019469","EFO_0004599","EFO_0002517","EFO_0006927","MONDO_0002367","MONDO_0018906","Orphanet_2781","HP_0100727","MONDO_0024880","EFO_0005784","EFO_0000519","MONDO_0000873","EFO_0003869","EFO_0001075","EFO_1000027","Orphanet_183660","EFO_1000131","Orphanet_848","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0009709","EFO_0000389","MONDO_0019088","EFO_0000182","EFO_0000330","MONDO_0019460","EFO_1000785","EFO_0000094","EFO_0009441","EFO_0003802","EFO_0005761","EFO_1000292","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0000223","MONDO_0044881","EFO_0002429","EFO_0003025","EFO_0009708","MONDO_0019474","Orphanet_811","EFO_0006926","MONDO_0001023","MONDO_0021193","EFO_0002428","EFO_1001051","EFO_0000218","MONDO_0002334","EFO_1000102","EFO_0003812","MONDO_0002542","MONDO_0019471","Orphanet_232","MONDO_0015686","EFO_1001945","EFO_0003778","EFO_1001469","HP_0001915","EFO_0000209","EFO_0000708","MONDO_0021063","MONDO_0002087","EFO_1002048","EFO_1000690","EFO_1000218","Orphanet_906","MONDO_0001657","EFO_0004272","MONDO_0020743","EFO_0000717","EFO_0010580","EFO_0002617","EFO_0000685","EFO_1000616","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0003865","MONDO_0005301","EFO_0000095","EFO_0006475","EFO_0000174","EFO_0000191","EFO_1000560","MONDO_0003219","MONDO_0020077","EFO_0000691","EFO_0003027","HP_0012410"],"count":164},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 129 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1114","canonicalSmiles":"Cn1cnc2c1c(=O)[nH]c(=O)n2C","inchiKey":"YAPQBXQYLJRXSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOBROMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diurobromine","FEMA NO. 3591","NSC-5039","SC-15090","Santheose","Theobromine","Theobromine(20%)","Theobrominum","Theosalvose","Xantheose"],"crossReferences":{"PubChem":["11111888","144203835","170465487","26751592","50104235","85231258","856014","90341332"],"Wikipedia":["Theobromine"],"drugbank":["DB01412"],"chEBI":["28946"]},"childChemblIds":["CHEMBL2106653","CHEMBL2107522","CHEMBL2107523"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1160508","canonicalSmiles":"N[C@@H](CS(=O)O)C(=O)O","inchiKey":"ADVPTQAUNPRNPO-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-Cysteinesulfinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Cysteinesulfinic Acid","L-Cysteinesulphinic Acid"],"crossReferences":{"PubChem":["11113410","26751649","50104341","90341125"],"drugbank":["DB02153"],"chEBI":["16345"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1195136","canonicalSmiles":"CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1","inchiKey":"AVDSOVJPJZVBTC-CTYIDZIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SNX 5422","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04929113","Pf-4929113","Snx 5422","Snx-5422"],"crossReferences":{"drugbank":["DB06070"]},"childChemblIds":["CHEMBL553939"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000574","MONDO_0044881","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1199734","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)Oc3ccccc3)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"ZHUWBKDWWGKIEN-FMKGYKFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1199734","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02790"]},"childChemblIds":["CHEMBL1162559"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200689","canonicalSmiles":"[N]=O","inchiKey":"MWUXSHHQAYIFBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRIC OXIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Genosyl","Inomax"],"synonyms":["Amidogen, oxo-","Inovent","Nitric oxide","Nitric oxide trimer","Nitrogen oxide (no)","Nitrosyl radical","OHM-11771"],"crossReferences":{"DailyMed":["nitric%20oxide"],"Wikipedia":["Nitric_oxide","Nitroxyl"],"drugbank":["DB00435"],"chEBI":["16480"]},"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["EFO_0001361","EFO_0007486","EFO_0004278","EFO_0007067","HP_0011950","EFO_1001923","EFO_1001951","EFO_0003103","EFO_1001459","EFO_0008585","EFO_0000544","EFO_0005046","EFO_0007216","EFO_0007541","EFO_0005762","EFO_0009686","MONDO_0005149","HP_0002093","HP_0200042","EFO_0009447","EFO_1001103","EFO_0002687","HP_0001919","HP_0100806","MP_0001845","MONDO_0100096","Orphanet_79364","MONDO_0004979","EFO_0000341","Orphanet_232","EFO_0000768","EFO_1000644","Orphanet_586","EFO_0000373","EFO_1000637","EFO_1001399","EFO_0003948","Orphanet_70589","EFO_0009444","EFO_1001375","EFO_0003144","EFO_0000712","MONDO_0005299","EFO_0004272","EFO_0003917","EFO_0000694","HP_0002094","EFO_0005207","EFO_0003818","EFO_0007512","EFO_0000537","EFO_0003106","EFO_0000684","EFO_0001068","EFO_0003827","EFO_0008583","EFO_0005611","MONDO_0043510","EFO_0009492"],"count":59},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 approved and 46 investigational indications."}
{"id":"CHEMBL1200694","canonicalSmiles":"FCOC(C(F)(F)F)C(F)(F)F","inchiKey":"DFEYYRMXOJXZRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVOFLURANE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"crossReferences":{"DailyMed":["sevoflurane"],"PubChem":["144205978","50112674"],"Wikipedia":["Sevoflurane"],"drugbank":["DB01236"],"chEBI":["9130"]},"linkedTargets":{"rows":["ENSG00000169427","ENSG00000109158","ENSG00000145863","ENSG00000082482","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000186795","ENSG00000171303","ENSG00000094755","ENSG00000100433","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000145888","ENSG00000186297","ENSG00000163288"],"count":22},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","EFO_0007486","HP_0012735","EFO_0011057","EFO_1001328","EFO_0004278","EFO_1001951","HP_0025425","EFO_0003931","EFO_0003870","EFO_0000544","EFO_0003884","EFO_1001250","EFO_0009686","EFO_0001074","EFO_0002687","EFO_0005323","HP_0001919","MP_0001914","MP_0001845","MONDO_0100096","EFO_0004888","EFO_0005109","EFO_0009659","EFO_0004337","EFO_0005251","MONDO_0018373","HP_0000303","EFO_0006834","MONDO_0021117","EFO_1001905","MONDO_0007254","EFO_0009267","EFO_1000637","EFO_1002048","MONDO_0002050","MONDO_0021698","EFO_0003839","EFO_0000616","EFO_0000694","EFO_0001645","EFO_0005207","HP_0011110","MONDO_0007576","EFO_0000313","EFO_1001884","MONDO_0004379","HP_0003418","EFO_0001073","EFO_0003843","EFO_0009549","EFO_0002615","EFO_0000537","EFO_0000311","HP_0000713","EFO_0001072","EFO_0003890","EFO_0000713","EFO_0008583","MONDO_0002367","EFO_0000612","EFO_0005611","MONDO_0043510","EFO_0003833","MONDO_0005178"],"count":66},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 31 investigational indications."}
{"id":"CHEMBL1200920","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.Cl","inchiKey":"MUFDLGGSOCHQOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOETHARINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201213","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-2","Bronkosol","Isoetharine hydrochloride","Isoetharine hydrochloride s/f","Numotac"],"synonyms":["Asthmalitan","Dl-isoetharine hydrochloride","Isoetarine hydrochloride","Isoetharine hcl","Isoetharine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201054","canonicalSmiles":"C[75Se]CC[C@H](N)C(=O)O","inchiKey":"RJFAYQIBOAGBLC-ZEMBQCNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENOMETHIONINE SE 75","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL113178","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Selenomethionine se 75","Sethotope"],"synonyms":["75se","Radioselenomethionine 75 se","Selenomethionine (75 se)","Selenomethionine (75Se)","Selenomethionine (75se)","Selenomethionine (75se) injection","Selenomethionine se 75","Selenomethionine se-75","Selenomethionine, l-, se-75","Selenomethionine, se-75","Selenomethionine,se-75"],"crossReferences":{"drugbank":["DB09400"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973."}
{"id":"CHEMBL1201192","canonicalSmiles":"NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1","inchiKey":"YFGHCGITMMYXAQ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARMODAFINIL","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Armodafinil","Nuvigil"],"synonyms":["Armodafinil","CEP-10952","CEP-10953","CRL-40982","Modafinil, (r)-","NSC-751850","NSC-758711","R-(-)-modafinil"],"crossReferences":{"DailyMed":["armodafinil"],"Wikipedia":["Armodafinil"],"drugbank":["DB06413"],"chEBI":["77590"]},"linkedTargets":{"rows":["ENSG00000142319"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0003888","MONDO_0005090","EFO_0005246","EFO_0006859","EFO_0005687","EFO_0000616","MONDO_0100342","HP_0000726","MONDO_0007576","EFO_0008568","EFO_0001073","EFO_0004698","EFO_0003060","MONDO_0002050","MONDO_0005301","EFO_0000712","MONDO_0043510","MONDO_0016158","EFO_0003047","EFO_0003918","EFO_0005411","HP_0012378","EFO_0003922"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 14 investigational indications."}
{"id":"CHEMBL1201315","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Technetium"],"crossReferences":{"chEBI":["33353"]},"childChemblIds":["CHEMBL4297443"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1201348","canonicalSmiles":"Cc1cc(OP(=O)(O)O)c2ccccc2c1OP(=O)(O)O","inchiKey":"JTNHOVZOOVVGHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENADIOL DIPHOSPHORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14650"]},"childChemblIds":["CHEMBL3989728"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201404","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl","inchiKey":"QLIIKPVHVRXHRI-CXSFZGCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mometasone"],"crossReferences":{"drugbank":["DB00764"],"chEBI":["6970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201448","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ARDEPARIN SODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Normiflo"],"synonyms":["Ardeparin sodium","Ardeparin sodium salt","RD-11885","WY-90493 RD","WY-90493-RD"],"crossReferences":{"Wikipedia":["Ardeparin_sodium"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL1201507","drugType":"Small molecule","blackBoxWarning":false,"name":"GLATIRAMER ACETATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Copaxone","Glatopa"],"synonyms":["COP-1","COPOLYMER-1","Glatiramer acetate"],"crossReferences":{"DailyMed":["glatiramer%20acetate"],"DrugCentral":["4880"],"Wikipedia":["Glatiramer_acetate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for multiple sclerosis and has 9 investigational indications."}
{"id":"CHEMBL1201514","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGADEMASE BOVINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adagen"],"synonyms":["Pegademase bovine"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 2 investigational indications."}
{"id":"CHEMBL1201554","drugType":"Protein","blackBoxWarning":false,"name":"ANTITHROMBIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atryn"],"synonyms":["Antithrombin (recombinant)","Antithrombin alfa","Antithrombin iii,recombinant","Human anti-thrombin-iii","KW-3357"],"linkedTargets":{"rows":["ENSG00000180210","ENSG00000126218"],"count":2},"linkedDiseases":{"rows":["HP_0005521","EFO_0000668"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1213447","canonicalSmiles":"O=C(Nc1cccc(-c2nnn[nH]2)c1)c1cccc(F)c1","inchiKey":"GAKOBKPDJJGRIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213447","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07729"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1","inchiKey":"VSZGPKBBMSAYNT-RRFJBIMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS 4104","GS-4071 ETHYL ESTER","GS-4104","GS4104","Oseltamivir","Oseltamivir Carboxylate","RO 640796","RO-64-0796","RO-640796","RO64-0796"],"crossReferences":{"DailyMed":["oseltamivir%20phosphate"],"Wikipedia":["Oseltamivir"],"drugbank":["DB00198"],"chEBI":["7798"]},"childChemblIds":["CHEMBL251990","CHEMBL1200340","CHEMBL3183419"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL1231969","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)c1","inchiKey":"OGADSZTVCUXSOK-PEBGCTIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231969","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04385"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235108","canonicalSmiles":"CC(=O)c1sc(Nc2ccccc2)nc1C","inchiKey":"UIIUOFPGDKBCEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235108","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["121285124"],"drugbank":["DB08359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236268","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)N(C=O)[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)cc1)CN2","inchiKey":"ZLOMJLIQXBKNHU-VJANTYMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236268","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02067"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237105","canonicalSmiles":"CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O.NC(CO)(CO)CO","inchiKey":"UMMADZJLZAPZAW-XOWPVRJPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBOPROST TROMETHAMINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237122","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hemabate"],"synonyms":["Carboprost trometamol","Carboprost trometanol","Carboprost tromethamine","Carboprost tromethamine salt","U-32,921E","U-32921E"],"crossReferences":{"DailyMed":["carboprost%20tromethamine"]},"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0009579"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for postpartum hemorrhage and hemorrhage. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1276308","canonicalSmiles":"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"VKHAHZOOUSRJNA-GCNJZUOMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIFEPRISTONE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Korlym","Mifegyne","Mifeprex"],"synonyms":["Mifepristone","NSC-759862","RU 38486","RU 486","RU-38486","RU-486","RU486"],"crossReferences":{"DailyMed":["mifepristone"],"PubChem":["11533034","144204503","144212158","170465151","26752198","26752199","50104862","50104863","50124354","56424093","90341299"],"drugbank":["DB00834"],"chEBI":["50692"]},"linkedTargets":{"rows":["ENSG00000082175","ENSG00000113580"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0002009","EFO_0001065","MONDO_0007254","EFO_0003768","EFO_1001110","MONDO_0002087","EFO_0002950","MONDO_0002046","MONDO_0002158","EFO_0000289","MONDO_0002050","EFO_0003099","EFO_0000673","EFO_0003047","MONDO_0007079","Orphanet_2495","EFO_0005230","EFO_0000400","EFO_1001255","EFO_1001757","HP_0012076","MONDO_0008170","EFO_0001358","EFO_0003060","MONDO_0008315","EFO_0009784","EFO_0007430","EFO_0006861","EFO_0000731","HP_0030369","EFO_0000764","MONDO_0011962","MONDO_0004975","EFO_0000432","MONDO_0001572"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for cushing syndrome and has 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1441961","canonicalSmiles":"CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1","inchiKey":"GFWRVVCDTLRWPK-KPKJPENVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFALCONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-88","Sofalcone","Solon"],"crossReferences":{"PubChem":["144205258","170466017","29215440"],"drugbank":["DB05197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15023","canonicalSmiles":"O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1","inchiKey":"GPMXUUPHFNMNDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUPERIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Triperidol"],"synonyms":["MCN-JR-2498","NSC-170978","R-2498","Trifluperidol"],"crossReferences":{"PubChem":["11111838","50111276","90340861"],"Wikipedia":["Trifluperidol"],"drugbank":["DB13552"]},"childChemblIds":["CHEMBL1257039"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL1620","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.Cl","inchiKey":"PCHPORCSPXIHLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE HYDROCHLORIDE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL657","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alledryl","Antitussive","Beldin","Belix","Benadryl","Benadryl preservative free","Benylin","Caladryl","Coltex","Dibenil","Diphen","Diphenhydramine hydrochloride","Diphenhydramine hydrochloride preservative free","Dreemon","Dytuss","Fedril","Gppe cough expect paed","Gppe oral soln","Histergan","Hydramine","Medinex","Nightcalm","Nytol","Nytol one-a-night","Paxidorm","Silphen","Sleepia","Syntedril","Tixylix catarrh","Vicks formula 44"],"synonyms":["Dimedrol","Diphenhydramine HCl","Diphenhydramine hcl","Diphenhydramine hydrochloride","NSC-33299"],"crossReferences":{"DailyMed":["diphenhydramine%20hydrochloride"],"PubChem":["144206544","144208670","144210928","26719640","26747495","26747496","26751624","50106145","50106146","50106147","543925","56422455","855936"],"chEBI":["4637"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005761","EFO_0005252","EFO_1000657","MONDO_0005271","MONDO_0007254","EFO_0000701","EFO_0000403","EFO_0003843","HP_0002315","HP_0002018","EFO_1000783","EFO_0002690","EFO_0000095","MONDO_0002367","HP_0002013","EFO_0004208"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and has 12 investigational indications."}
{"id":"CHEMBL1697833","canonicalSmiles":"CC(C)(N)Cc1ccccc1Cl","inchiKey":"HXCXASJHZQXCKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORTERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clortermine"],"crossReferences":{"PubChem":["170466437"],"Wikipedia":["Clortermine"],"drugbank":["DB01527"]},"childChemblIds":["CHEMBL2107635"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1719398","canonicalSmiles":"c1ccc(C2(N3CCCC3)CCCCC2)cc1","inchiKey":"FYOWWXMGDATDQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLICYCLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rolicyclidine"],"crossReferences":{"PubChem":["144205385","29216146"],"drugbank":["DB01549"],"chEBI":["60805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1790006","canonicalSmiles":"Cc1cc2nc3ccc(N(C)C)cc3[s+]c2cc1N.[Cl-]","inchiKey":"HNONEKILPDHFOL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLONIUM CHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1622638","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Blutene"],"synonyms":["Basic blue 17","Blutene chloride","C.i. 52040","C.i. basic blue 17","Ci 52040","Gabilin","Menodin","NSC-11225","NSC-36758","Schultz 1041","Tolazul","Tolonium chloride","Toluidine blue o","Toluidine blue oo"],"crossReferences":{"PubChem":["144206710","170466390","540036"],"chEBI":["87647"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190265","canonicalSmiles":"O=C(O)[C@]1(O)C=C[C@@H](O)[C@H](O)C1","inchiKey":"VTEDVYGIJPLVFF-XAHCXIQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Anhydroquinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Anhydroquinic Acid"],"crossReferences":{"drugbank":["DB02801"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908315","canonicalSmiles":"CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)OC","inchiKey":"KYBOHGVERHWSSV-VNIVIJDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMEPROST","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cervagem"],"synonyms":["Gemeprost","Preglandin","SC-37681","U-37026"],"crossReferences":{"drugbank":["DB08964"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1908917","canonicalSmiles":"N[C@]1(C(=O)O)C[C@@H](F)C1","inchiKey":"NTEDWGYJNHZKQW-IWLYVCSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1908917","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15237"]},"childChemblIds":["CHEMBL254468"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196003","canonicalSmiles":"CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"QFFCYTLOTYIJMR-XMGTWHOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMEGESTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Promegestone","Surgestone"],"crossReferences":{"drugbank":["DB13602"],"chEBI":["73390"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19611","canonicalSmiles":"CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"NITYDPDXAAFEIT-DYVFJYSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILOMASTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galardin","Gm6001","Ilomastat"],"crossReferences":{"PubChem":["144205608","26756835","50111444"],"drugbank":["DB02255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197199","canonicalSmiles":"CNC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@@H](C)NC(=O)C[C@@H](C(=O)O)NC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](Cc2ccccc2)N(C)C1=O","inchiKey":"UHBHXSDKGLPPGO-HTDHLNIYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ARGIFIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Argifin"],"crossReferences":{"drugbank":["DB03632"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203517","canonicalSmiles":"CNC(=O)[C@@H]1Cc2ccc(NS(=O)(=O)O)cc2CN1C(=O)OC(C)(C)C","inchiKey":"PPSSYXOFPICMQD-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203517","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06887"]},"childChemblIds":["CHEMBL382885"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048028","canonicalSmiles":"CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1","inchiKey":"JFOZKMSJYSPYLN-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFITEGRAST","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xiidra"],"synonyms":["Lifitegrast","SAR 1118","SAR-1118","SHP-606","SHP606"],"crossReferences":{"DailyMed":["lifitegrast"],"drugbank":["DB11611"]},"childChemblIds":["CHEMBL2048409","CHEMBL2048410"],"linkedTargets":{"rows":["ENSG00000005844","ENSG00000160255"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0003966","EFO_1000906","EFO_0009464","EFO_0007141","EFO_0009321"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for dry eye syndrome and eye disease and has 2 investigational indications."}
{"id":"CHEMBL2062774","canonicalSmiles":"CCOc1noc2cc(OCCC3CCN(c4ccc(C)nn4)CC3)ccc12","inchiKey":"DKSVBVKHUICELN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAPENDAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTA-798","BTA798","Bta798","Vapendavir"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104325","canonicalSmiles":"O=C1c2ccc(Br)cc2C(=O)C1c1ccccc1","inchiKey":"QFLZIWVSQDZLNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOBROMINDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isobromindione"],"crossReferences":{"drugbank":["DB13545"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105749","canonicalSmiles":"NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3.O=C(O)C[C@H](O)C(=O)O","inchiKey":"RARHXUAUPNYAJF-QSYGGRRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMIDORPHAN L-MALATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL426084","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["RDC-0313-02","Samidorphan l-malate"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0009963"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for schizophrenia and bipolar i disorder."}
{"id":"CHEMBL2105842","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"RKHQGWMMUURILY-UHRZLXHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTIVAZOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Altim"],"synonyms":["Cortivazol","NSC-80998"],"crossReferences":{"drugbank":["DB13003"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2106124","canonicalSmiles":"O=P([O-])([O-])OCC(O)CO.[Ca+2]","inchiKey":"IWIRHXNCFWGFJE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLYCEROPHOSPHATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium glycerinophosphate","Calcium glycerophosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106575","canonicalSmiles":"CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO.F.F","inchiKey":"ZVVSSOQAYNYNPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLAFLUR","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110901","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olaflur","Olafur","SK&F 38095","SKF-38095"],"crossReferences":{"drugbank":["DB13290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107863","drugType":"Unknown","blackBoxWarning":false,"name":"RINDOPEPIMUT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-110","PF-04948568","PF-04948568 (FORMERLY CDX-110)","Rindopepimut"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["MONDO_0100342","EFO_1001465","MONDO_0001657"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108339","drugType":"Protein","blackBoxWarning":false,"name":"EGAPTIVON PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC-1779","ARC1779","Arc1779","Egaptivon pegol"],"linkedTargets":{"rows":["ENSG00000110799"],"count":1},"linkedDiseases":{"rows":["Orphanet_903","MONDO_0000831","MONDO_0018896"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108626","drugType":"Cell","blackBoxWarning":false,"name":"ONAMELATUCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Canvaxin"],"synonyms":["Onamelatucel-l"],"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109369","drugType":"Antibody","blackBoxWarning":false,"name":"90Y-CT84.66","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["90Y-CT84.66"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109395","drugType":"Antibody","blackBoxWarning":false,"name":"ZATUXIMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zatuximab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109459","drugType":"Antibody","blackBoxWarning":false,"name":"CDP-484","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-484"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109479","drugType":"Antibody","blackBoxWarning":false,"name":"PF-03475952","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03475952"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111078","canonicalSmiles":"Cc1nc(NS(=O)(=O)c2ccc(N)cc2)nc(C)c1Br","inchiKey":"KWXCNODTHBHSIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFABROMOMETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-5874"],"crossReferences":{"PubChem":["144206282"],"drugbank":["DB11547"]},"childChemblIds":["CHEMBL3989656"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146124","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@H]12)c1ccco1.[Na+]","inchiKey":"URDOHUPGIOGTKV-JTBFTWTJSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFUROXIME SODIUM","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1436","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Britacef","Cefuroxime sodium","Kefurox","Zinacef"],"synonyms":["Cefuroxime","Cefuroxime sodium","Cefuroxime sodium salt","Sodium cefuroxime"],"crossReferences":{"DailyMed":["cefuroxime%20sodium"],"chEBI":["3517"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL2177390","canonicalSmiles":"CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1","inchiKey":"GRZXWCHAXNAUHY-NSISKUIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPATASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0068","Ipatasertib","RG-7440","RG7440","Rg-7440"],"crossReferences":{"drugbank":["DB11743"]},"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0003893","EFO_0000503","MONDO_0008170","MONDO_0007254","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0001056","EFO_0005537","MONDO_0011962","EFO_0000196"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2359670","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)CC(O)C(=O)O.O=C(O)CC(O)C(=O)O","inchiKey":"GTHHLZDYRHLACN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE MALATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Torecan"],"synonyms":["Thiethylperazine dimalate","Thiethylperazine malate","Thietylperazine malate"],"crossReferences":{"PubChem":["144204335"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL2368924","canonicalSmiles":"CS(=O)(=O)O.O.O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12","inchiKey":"QTFFGPOXNNGTGZ-LIFGOUTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASETRON MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2368925","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anzemet"],"synonyms":["Dolasetron mesilate","Dolasetron mesilate monohydrate","Dolasetron mesylate","Dolasetron mesylate anhydrous","Dolasetron mesylate monohydrate","Dolasetron methanesulfonate","MDL 73,147EF","MDL-73147EF"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["HP_0002017","EFO_0004888","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved indications."}
{"id":"CHEMBL252124","canonicalSmiles":"CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1","inchiKey":"JXPCDMPJCKNLBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VER-50589","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VER-50589"],"crossReferences":{"drugbank":["DB06964"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255069","canonicalSmiles":"Cc1cc(C)cc(-c2nc3ccccc3o2)c1","inchiKey":"BIHLSRJPJFOESJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(3,5-Dimethylphenyl)Benzo[D]Oxazole","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(3,5-Dimethylphenyl)Benzo[D]Oxazole"],"crossReferences":{"drugbank":["DB08207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257705","canonicalSmiles":"Cc1cc(-c2c(-c3ccccc3)c3cc(Cl)ccc3[nH]c2=O)on1","inchiKey":"QINNOQKHPLWGBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257705","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27","canonicalSmiles":"CC(C)NCC(O)COc1cccc2ccccc12","inchiKey":"AQHHHDLHHXJYJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPRANOLOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".beta.-propranolol","AY-64043-","Betalong","Dl-propranolol","Euprovasin","Inderal","Inderide-40/25","Inderide-80/25","Propranolol","Proprasylyt","Reducor"],"crossReferences":{"DailyMed":["propranolol%20hydrochloride"],"PubChem":["124881056","26751802","26755283","50104497","90341556"],"Wikipedia":["Propranolol"],"drugbank":["DB00571"],"chEBI":["8499"]},"childChemblIds":["CHEMBL1671"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0002610","EFO_0004262","EFO_0004280","MONDO_0002009","EFO_0000275","EFO_0000756","EFO_0000681","EFO_0004278","EFO_0003768","EFO_1001917","EFO_0009322","Orphanet_79383","EFO_0003913","EFO_1000911","EFO_1001450","HP_0004755","EFO_0000389","EFO_0000182","HP_0003419","EFO_1000802","EFO_0003756","EFO_1001466","MONDO_0002363","HP_0001636","EFO_0009516","EFO_1001968","Orphanet_558","EFO_0000666","EFO_0001663","HP_0001279","MONDO_0100431","EFO_0000546","EFO_0001422","MONDO_0004979","EFO_0009545","EFO_0000341","HP_0001943","EFO_0001378","EFO_0003108","EFO_1001158","EFO_0005251","EFO_0003086","EFO_0005687","Orphanet_232","EFO_0005252","MONDO_0007254","Orphanet_221061","EFO_0003882","MONDO_0001187","MONDO_0005277","MONDO_0001056","EFO_1000218","EFO_0009444","EFO_0003968","EFO_1001375","EFO_0003860","HP_0030834","EFO_0000712","EFO_1000645","EFO_0004242","EFO_0005230","EFO_1000635","HP_0001541","EFO_0004319","HP_0001337","EFO_0004269","EFO_0004329","EFO_0000478","EFO_1001884","EFO_0001358","EFO_0000319","EFO_0001073","EFO_0009189","HP_0002315","EFO_0003843","EFO_0000537","EFO_0000311","EFO_0001072","Orphanet_230","MONDO_0021661","EFO_0004287","Orphanet_774","MONDO_0005147","EFO_0004142","EFO_0000612","MONDO_0043510","EFO_0003918","MONDO_0005148","MONDO_0005475"],"count":90},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 8 approved and 70 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL274467","canonicalSmiles":"CC(=O)c1ccccc1","inchiKey":"KWOLFJPFCHCOCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOPHENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetophenone"],"crossReferences":{"PubChem":["144209620"],"Wikipedia":["Acetophenone"],"drugbank":["DB04619"],"chEBI":["27632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277522","canonicalSmiles":"O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1","inchiKey":"ZPAKPRAICRBAOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENBUFEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinopal","Fenbuzip 300","Fenbuzip 450","Lederfen 450","Lederfen cp","Lederfen f"],"synonyms":["CL 82,204","CL-82204","Fenbufen","NSC-757812"],"crossReferences":{"PubChem":["11112746","11533001","124882584","144204189","170465799","26748465","56423138"],"Wikipedia":["Fenbufen"],"drugbank":["DB08981"],"chEBI":["31599"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL284377","canonicalSmiles":"N[C@@H](COP(=O)(O)O)C(=O)O","inchiKey":"BZQFBWGGLXLEPQ-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXFOSFOSERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexfosfoserine","Fosforina","GNF-PF-1028","L-o-phosphoserine","L-o-serine phosphate","L-phosphoserine","NSC-760136","O-phosphoryl-l-serine","O-phosphoserine, l-","Serine phosphate","Seriphos"],"crossReferences":{"PubChem":["11113423","144205603","170466581","26751660","50104360","50104361","90341677"],"Wikipedia":["Phosphoserine"],"drugbank":["DB04522"],"chEBI":["15811"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289191","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"MQYXUWHLBZFQQO-QGTGJCAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUPEOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clerodol","Fagarasterol","Farganasterol","Lupeol","Monogynol B"],"crossReferences":{"PubChem":["397292"],"Wikipedia":["Lupeol"],"drugbank":["DB12622"],"chEBI":["6570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296323","canonicalSmiles":"C[C@](O)(CBr)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"QDSWNDMHSBZXKX-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL296323","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07454"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL311228","canonicalSmiles":"CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21","inchiKey":"XZEFMZCNXDQXOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL311228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185126","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"SFKQVVDKFKYTNA-DZCXQCEKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL3185126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206485"],"drugbank":["DB00093"],"chEBI":["60564"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188091","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC","inchiKey":"DXPHNGAMYPPTBJ-TZMIJSMNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SOVATELITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IRL-1620","Irl-1620","PMZ-1620","SPI 1620","SPI-1620","Sovatelitide","Sovateltide","Spi 1620","Spi-1620"],"crossReferences":{"PubChem":["50112622"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3189072","canonicalSmiles":"CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O.Cl.O","inchiKey":"HWAAPJPFZPHHBC-FGJQBABTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROFIBAN HYDROCHLORIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL916","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aggrastat"],"synonyms":["L-700,462","L-700462","MK-383","Tirofiban hcl","Tirofiban hydrochloride"],"crossReferences":{"DailyMed":["tirofiban%20hydrochloride"],"PubChem":["144206533","170465092"],"chEBI":["9606"]},"linkedTargets":{"rows":["ENSG00000259207","ENSG00000005961"],"count":2},"linkedDiseases":{"rows":["EFO_0000612"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1998 and is indicated for myocardial infarction."}
{"id":"CHEMBL319669","canonicalSmiles":"CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1","inchiKey":"UKOQVLAXCBRRGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAFURAMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pafuramidine"],"crossReferences":{"Wikipedia":["Pafuramidine"],"drugbank":["DB06532"]},"childChemblIds":["CHEMBL2107359","CHEMBL4103116"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3349001","canonicalSmiles":"CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(-c3cnco3)c(OC)c2)c1","inchiKey":"GYCPCOJTCINIFZ-OXJNMPFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVN-944","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVN 944","AVN944","Avn-944","Avn944"],"linkedTargets":{"rows":["ENSG00000106348","ENSG00000178035"],"count":2},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL338975","canonicalSmiles":"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O","inchiKey":"HZOTZTANVBDFOF-PBCQUBLHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYSOSTIGMINE SALICYLATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL94","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antilirium","Isopto eserine"],"synonyms":["Eserine salicylate","NSC-757275","Physostigmine monosalicylate","Physostigmine salicylate","Physostigmini salicylas"],"crossReferences":{"PubChem":["855875"],"chEBI":["48883"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3544954","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"OOUACICUAVTCEC-LZHWUUGESA-N","drugType":"Protein","blackBoxWarning":false,"name":"ZOPTARELIN DOXORUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AN-152","Aezs-108","Zoptarelin doxorubicin"],"childChemblIds":["CHEMBL3989956"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0011962","EFO_0008528","MONDO_0007254"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545014","drugType":"Small molecule","blackBoxWarning":false,"name":"AM-461","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Am-461"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545090","drugType":"Small molecule","blackBoxWarning":false,"name":"RXDX-103","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rxdx-103"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545186","canonicalSmiles":"Cc1cc2c(CCc3sc(-c4ccc(C(F)(F)F)cc4)nc3C(C)C)noc2cc1OCC(=O)O","inchiKey":"WWKYLBGQYALEDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FONADELPAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fonadelpar","NPS-005","SJP-0035"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545278","canonicalSmiles":"CCCCCS(=O)(=O)NC(=O)c1ccc2nc(C)n(Cc3ccc(Cl)cc3Cl)c2c1","inchiKey":"UYGZODVVDUIDDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATX08-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atx08-001","FK-614","FK614"],"crossReferences":{"drugbank":["DB12557"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545347","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"PVHLMTREZMEJCG-GDTLVBQBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TXA127","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-ile-angiotensin-(1-7)","Angiotensin (1-7)","Angiotensin 1-7","Angiotensin fragment 1-7","Angiotensin peptide (1-7)","Angiotensin-(1-7)","Asp-arg-val-tyr-ile-his-pro","Bf-angiotensin 1-7","Human angiotensin ii (1-7)","Sh-heptapeptide-13","TXA-127","TXA127","Txa127"],"crossReferences":{"drugbank":["DB11720"],"chEBI":["55438"]},"linkedTargets":{"rows":["ENSG00000130368"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0009686","MONDO_0100096","EFO_0000764","EFO_0001073","EFO_0004265","EFO_0000537","EFO_0000311"],"count":9},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3545350","canonicalSmiles":"Cc1nccn1Cc1cc(-c2ccc(F)c(C(F)F)c2)cnn1","inchiKey":"BOVUHBFXPNLTKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVT-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3545349"],"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL364092","canonicalSmiles":"Oc1ccc(-c2ccc3c(Cl)c(O)ccc3c2)cc1","inchiKey":"YHEHVRSGKUYDON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL364092","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07119"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL364811","canonicalSmiles":"CN(CCO)c1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"VDJWWYRYKMXMKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL364811","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07654"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379218","canonicalSmiles":"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12","inchiKey":"BPNUQXPIQBZCMR-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-674563","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-674563"],"crossReferences":{"drugbank":["DB08568"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3828009","canonicalSmiles":"C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl","inchiKey":"GKJCVYLDJWTWQU-CXLRFSCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3828009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13022"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833334","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.COc1ccc2c3c1OC1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.Cl.Cl.Cl","inchiKey":"LGFMXOTUSSVQJV-LYAFVJFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAPAVERETUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833406","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnopon-scopolamine"],"synonyms":["Papaveretum"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL3833389","canonicalSmiles":"C[C@@H](CC(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1)N1CCOCC1","inchiKey":"XHKXWINHANRSNT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMORAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acscn-9613","Alcoid","Dextromoramide","IDS-ND-003","Jetrium","Linfadol","MCP-875","Moramide","Narcolo","Palfadonna","R-875","Racemoramide, (s)-","SKF-5137","Troxilan","Yetrium"],"childChemblIds":["CHEMBL3833311"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL3989918","canonicalSmiles":"CCc1noc(CC)c1C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C","inchiKey":"GLIUZQUNUNICGS-XUBYYPQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INGENOL DISOXATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ingenol disoxate","LEO 43204","LEO-43204","LEO43204"],"crossReferences":{"drugbank":["DB15109"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4105584","canonicalSmiles":"COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1[C@H]3CC[C@@H]1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21","inchiKey":"ZTTKEBYSXUCBSE-QDFUAKMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4105584","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12225"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420762","canonicalSmiles":"Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1","inchiKey":"WRNXUQJJCIZICJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOZAVAPTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mozavaptan","Mozavaptane"],"crossReferences":{"PubChem":["170466304"],"Wikipedia":["Mozavaptan"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297511","canonicalSmiles":"N[C@@H](CCS(=O)(=O)O)CSSC[C@@H](N)CCS(=O)(=O)O","inchiKey":"HJPXZXVKLGEMGP-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRIBASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firibastat","QGC001","Qgc-001","Qgc001","RB-150"],"crossReferences":{"drugbank":["DB13107"]},"linkedTargets":{"rows":["ENSG00000138792"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0003144","EFO_0000612","EFO_1002048","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297557","drugType":"Unknown","blackBoxWarning":false,"name":"MICROCRYSTALLINE CELLULOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cellulose","Cellulose microcrystalline","Microcrystalline cellulose"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297582","canonicalSmiles":"O=C(CCCCCCC(=O)Nc1ccc(CN[C@H](C(=O)OC2CCCC2)c2ccccc2)cc1)NO","inchiKey":"GLNWREBYRLDPQP-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEFINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tefinostat"],"crossReferences":{"drugbank":["DB15321"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297602","canonicalSmiles":"O=c1[nH]c(=O)c(Cc2cccc(C(F)(F)F)c2)c([C@H]2CC[C@H](c3ccccc3)CC2)[nH]1","inchiKey":"GVVUZBSCYAVFTI-IYARVYRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRICORILANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CORT-118335","CORT118335","Cort118335","Miricorilant"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297650","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)[C@H](C)O)[C@H](C)O","inchiKey":"BAAXVYBAMNDCIB-BMCUWHFPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BRIMAPITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brimapitide","Xg-102"],"crossReferences":{"drugbank":["DB15231"]},"linkedTargets":{"rows":["ENSG00000109339"],"count":1},"linkedDiseases":{"rows":["MP_0001845"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297664","canonicalSmiles":"CC[C@@]1(OC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]cn2)NC(=S)Nc2ccc(O[C@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)[C@@H]3O)cc2)C(C)C)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1.Cl","inchiKey":"XQWYWSHYKUJQDC-NZGUGFNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFELETECAN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105857","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afeletecan hydrochloride","BAY 56-3722","BAY-563722","BAY56-3722","Bay 38-3441","Bay 56-3722"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297680","drugType":"Unknown","blackBoxWarning":false,"name":"1018 ISS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1018 ISS","1018 iss","CPG-1018","Cpg 1018","Cpg oligonucleotide 1018 iss","Iss 1018","Iss-1018"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000764","EFO_0004142","EFO_0004197","EFO_0005952"],"count":5},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297803","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGZILARGINASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEB-1102","AEB1102","Aeb1102","Co-argi-peg","Pegzilarginase"],"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298003","drugType":"Unknown","blackBoxWarning":false,"name":"AMELPARIB DIHYDROCHLORIDE DIHYDRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amelparib dihydrochloride dihydrate","JPI-289","Jpi-289"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL434025","canonicalSmiles":"O=C(NCCOCCOCCNC(=O)c1cc2cc(Cl)ccc2[nH]1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"MWWXABBBAPKJDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL434025","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447686","canonicalSmiles":"CC(=O)Oc1c(OC(C)=O)c(C=O)c2c(OC(C)=O)c(-c3c(C)cc4c(C(C)C)c(OC(C)=O)c(OC(C)=O)c(C=O)c4c3OC(C)=O)c(C)cc2c1C(C)C","inchiKey":"LJKDPUCDUDLUOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOSSYPOL ACETIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gossypol acetate","Gossypol acetic acid","NSC-19048"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL451432","canonicalSmiles":"N#C/N=C1\\SCCN1Cc1ccc(Cl)nc1","inchiKey":"HOKKPVIRMVDYPB-UVTDQMKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIACLOPRID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["thiacloprid"],"crossReferences":{"PubChem":["144211014","26757860","29216460"],"Wikipedia":["Thiacloprid"],"drugbank":["DB08620"],"chEBI":["39176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459177","canonicalSmiles":"COc1cc(-c2ccccc2)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"JPENSYBRTSIYGO-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL459177","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07140"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594440","canonicalSmiles":"Fc1cc(F)c2c(c1)C[C@@H](n1c(CCNCc3ccccc3)c[nH]c1=S)CO2","inchiKey":"ZSSLCFLHEFXANG-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZAMICASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zamicastat"],"linkedTargets":{"rows":["ENSG00000123454"],"count":1},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594517","drugType":"Antibody","blackBoxWarning":false,"name":"GILORALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-927","Abbv-927","Giloralimab","PR-1614645"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594594","drugType":"Antibody","blackBoxWarning":false,"name":"ITEPEKIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Itepekimab","REGN-3500","REGN3500","Regn3500","SAR-440340","SAR440340","Sar440340"],"linkedTargets":{"rows":["ENSG00000137033"],"count":1},"linkedDiseases":{"rows":["EFO_0010638","MONDO_0004979","EFO_0000341","EFO_0000274"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL460258","canonicalSmiles":"C[C@@H]1C[C@@H]2C(=C3CCC(=O)C=C31)[C@@H](c1ccc(N(C)C)cc1)C[C@@]1(C)[C@H]2CC[C@@]12CCCO2","inchiKey":"HFDGABTZPISMDD-IEVXGSBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460258","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15585"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46293","canonicalSmiles":"O=CNCc1ccccc1","inchiKey":"IIBOGKHTXBPGEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Benzyl-Formamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Benzyl-Formamide"],"crossReferences":{"drugbank":["DB02481"],"chEBI":["41117"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650458","drugType":"Antibody","blackBoxWarning":false,"name":"RUNIMOTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTRC-4017A","BTRC4017A","Btrc4017a","RG-6194","Runimotamab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL476186","canonicalSmiles":"CO[C@@H]1C[C@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)N(C(=O)Nc2ccc(Cl)cc2)C1","inchiKey":"QQBKAVAGLMGMHI-WIYYLYMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERIBAXABAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["292","Eribaxaban","PD 348","PD 348,292","PD-0348292","PD-348","PD-348292"],"crossReferences":{"drugbank":["DB06920"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483849","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N","inchiKey":"NOTGFIUVDGNKRI-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483849","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["AICA_ribonucleotide"],"drugbank":["DB01700"],"chEBI":["18406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496","canonicalSmiles":"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl","inchiKey":"ACGUYXCXAPNIKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXACHLOROPHENE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["\"germa-medica \"\"mg\"\"\"","E-z scrub","Gamophen","Germa-Medica \"Mg\"","Germa-medica","Hexa-germ","Hexascrub","Phiso-scrub","Phisohex","Pre-op","Pre-op ii","Scrubteam surgical spongebrush","Septi-soft","Septisol","Soy-dome","Turgex"],"synonyms":["Hexachlorophene"],"crossReferences":{"PubChem":["144204650","144208548","144213058","170464690","17389858","26747319","26747320","26752933","50105541","56422370","56436644","8139957","99234229"],"Wikipedia":["Hexachlorophene"],"drugbank":["DB00756"],"chEBI":["5693"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949."}
{"id":"CHEMBL51149","canonicalSmiles":"COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"XQLWNAFCTODIRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLOPAMIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gallopamil"],"crossReferences":{"PubChem":["104171189","124880748","26752312","26752313","50105237","50105238","90341545"],"Wikipedia":["Gallopamil"],"drugbank":["DB12923"],"chEBI":["34772"]},"childChemblIds":["CHEMBL1256940"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL549963","canonicalSmiles":"CN(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2","inchiKey":"QTWZICCBKBYHDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROMETHYLTHIONINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydromethylthionine","Leucomethylene blue","Leukomethylene blue","Methylene blue leuco form","Methylene blue, leuco","Reduced methylene blue"],"childChemblIds":["CHEMBL4297221"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL564249","canonicalSmiles":"CS(=O)(=O)c1cccc(C(=O)NC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cccc(Cl)c2)c1","inchiKey":"QRGBOABBMKYMLG-UXHICEINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL564249","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08429"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL614","canonicalSmiles":"NC(=O)c1cnccn1","inchiKey":"IPEHBUMCGVEMRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZINAMIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pirilene","Pyrafat","Pyrazinamide","Tebrazid"],"synonyms":[".alpha.-pyrazinamide","Aldinamid","Aldinamide","D-50","Eprazin","Farmizina","Isopas","MK-56","NSC-14911","Novamid","Pirazimida","Pirazinamid","Pyramizade","Pyrazide","Pyrazinamide","Pyrazinamidum","Pyrazine carboxylamide","Pyrazinecarboxamide","Rozide","Unipyranamide","Zinamide"],"crossReferences":{"DailyMed":["pyrazinamide"],"PubChem":["11111657","121269831","144209257","144213088","170464703","17389747","174007270","26752748","50105394","8139959","90341475"],"Wikipedia":["Pyrazinamide"],"drugbank":["DB00339"],"chEBI":["45285"]},"childChemblIds":["CHEMBL1091434"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for tuberculosis and pulmonary tuberculosis and has 5 investigational indications."}
{"id":"CHEMBL644","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2CCc2ccccc21","inchiKey":"ZSCDBOWYZJWBIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIMIPRAMINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surmontil"],"synonyms":["7162 RP","7162-RP","IL 6001","IL-6001","Surmontil","Trimeproprimine","Trimipramine"],"crossReferences":{"DailyMed":["trimipramine%20maleate"],"PubChem":["50111256","90341093"],"Wikipedia":["Trimipramine"],"drugbank":["DB00726"],"chEBI":["9738"]},"childChemblIds":["CHEMBL1200948"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000149295","ENSG00000102468","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000196639","ENSG00000147246"],"count":8},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0003761","EFO_0005230"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for unipolar depression and depressive disorder and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL73234","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1","inchiKey":"CFJMRBQWBDQYMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBETAPENTANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Pentoxyverine"],"crossReferences":{"PubChem":["11113506","144204460","170465562","26751724","50104415","50104416","90340636"],"Wikipedia":["Pentoxyverine"],"drugbank":["DB11186"]},"childChemblIds":["CHEMBL1256696"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","HP_0012735"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cough and sinusitis. It was withdrawn in United States."}
{"id":"CHEMBL742","canonicalSmiles":"CNC1(c2ccccc2Cl)CCCCC1=O","inchiKey":"YQEZLKZALYSWHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETAMINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"crossReferences":{"DailyMed":["ketamine%20hydrochloride"],"PubChem":["144205256","29215438","56424156"],"Wikipedia":["Esketamine","Ketamine"],"drugbank":["DB01221"],"chEBI":["6121"]},"childChemblIds":["CHEMBL1714"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0003777","HP_0000989","EFO_0002610","EFO_0004777","MONDO_0002009","EFO_0003015","EFO_0003768","EFO_1001917","Orphanet_778","EFO_0004321","HP_0100543","MONDO_0002358","EFO_0003931","EFO_0003819","EFO_0009513","MONDO_0008903","EFO_1001898","HP_0003419","EFO_0009552","HP_0012378","EFO_0009620","EFO_0003877","MONDO_0002038","EFO_0005762","EFO_0008526","EFO_0003756","HP_0000360","EFO_0009686","EFO_1000864","EFO_0001074","EFO_0007623","HP_0012532","HP_0012076","EFO_0005323","EFO_0009516","MONDO_0008315","EFO_0000546","HP_0100806","MP_0001914","MP_0001845","MONDO_0100096","MONDO_0001208","EFO_0007430","EFO_0003957","EFO_0004888","EFO_0007634","EFO_0000341","HP_0025428","MONDO_0002258","HP_0030680","EFO_0005223","EFO_0004320","MONDO_0005090","MONDO_0000726","EFO_0003086","EFO_1001998","EFO_1001219","EFO_0006834","Orphanet_232","EFO_0007453","MONDO_0007254","EFO_0009267","EFO_1000637","EFO_0007191","MONDO_0005277","EFO_0000289","MONDO_0002050","EFO_0000474","MONDO_0005129","EFO_0000712","EFO_0003839","EFO_0009854","EFO_0003761","EFO_0007224","EFO_0002460","EFO_0005279","MONDO_0007079","EFO_0004242","EFO_0004215","EFO_0000694","HP_0002140","HP_0000486","EFO_0008590","EFO_0001645","EFO_0000677","EFO_0009658","EFO_0009963","MONDO_0000870","EFO_0001358","EFO_1001884","EFO_0003843","HP_0002315","EFO_0000311","HP_0000713","EFO_0007149","EFO_1001412","HP_0001082","EFO_0003890","EFO_0000713","EFO_0000512","Orphanet_1480","EFO_0005611","MONDO_0043510","EFO_0003918","HP_0000023","EFO_0009492","MONDO_0024417"],"count":109},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 77 investigational indications."}
{"id":"CHEMBL85164","canonicalSmiles":"CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1.CS(=O)(=O)O","inchiKey":"FSEKIHNIDBATFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMOSTAT MESILATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL590799","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camostat mesilate","Camostat mesylate","Camostat methanesulfonate"],"crossReferences":{"PubChem":["170465784"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL990","canonicalSmiles":"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12","inchiKey":"ABJKWBDEJIDSJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTENAFINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butenafine","Mentax","Mentax-TC"],"crossReferences":{"DailyMed":["butenafine%20hydrochloride"],"PubChem":["144205282","170465093","29215487"],"Wikipedia":["Butenafine"],"drugbank":["DB01091"],"chEBI":["3238"]},"childChemblIds":["CHEMBL1200397"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for tinea and has 3 investigational indications."}
